$LUCD 💥BOOM💥 Just secured a major commercial coverage win. Concert (now part of Lyric) issued a positive policy for EsoGuard THAT recognizing it as the only esophageal precancer test that meets its criteria. Lyric reaches ~185M covered lives and 9 of the top 10 U.S. health plans. Multiple plans have already adopted it. MONEY-LINE: “$60B TAM” Market is still asleep. This is the kind of quiet coverage expansion that can drive a 10x+ move. Dominos are lining up. Could get MEDICARE LCD tomorrow or any time. Already has a Medicare published price. This is your 10x. https://t.co/E9evZbPazD
View on X ↗